A new study at the University of London College, UK, has shown that medications used to treat diabetes can reduce the risk of developing Parkinson’s disease, opening up a range of potential options for treating and managing a degenerative brain disorder..
According to a newspaper report sciencealert Scientific, the study examined the patient records of 100,288 people with type 2 diabetes, scientists found that while these individuals had a higher than usual risk of developing Parkinson’s disease, it appears that Diabetes medications Which is commonly prescribed reduces this risk.
The researchers confirmed that people who were taking two specific types of diabetes drugs receptor agonists GLP-1 And inhibitors DPP4 – They were 60% less likely to develop Parkinson’s disease later in life than those taking other treatments..
Neuroscientist Tom Folteney from London College, UK, said: “Our study has reinforced the evidence for a link between type 2 diabetes and Parkinson’s disease, although it remains clear that most diabetics will not continue to develop Parkinson’s disease.“.
The research continues a study conducted since 2018 that covered nearly two million people with type 2 diabetes, and showed that while the chances of developing Parkinson’s disease remained low, the incidence of diabetes increased this chance by about a third although it is not clear why. exactly.
– .
